The Addition of Darolutamide to Androgen Deprivation Therapy and Docetaxel in a 55-Year-Old Man With Metastatic Hormone-Sensitive Prostate Cancer
Clinical advances in hematology & oncology : H&O（2022）
关键词
darolutamide,prostate cancer,androgen deprivation therapy,year-old,hormone-sensitive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要